Skip to content

(Cost)-effectiveness of lower extremity nerve decompression surgery in diabetic subjects: the DeCompression (DECO) trial

(Cost)-effectiveness of lower extremity nerve decompression surgery in diabetic subjects: the DeCompression (DECO) trial - DECO trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54529
Enrollment
344
Registered
2019-09-19
Start date
2019-12-16
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot Neuropathy polyneuropathy

Interventions

In the intervention group, a surgical release of at least the tibial and common peroneal nerves, additional decompressions of the superficial and deep peroneal nerves can be carried out when compres

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Having diabetes mellitus (type 1 or 2) Patients (> 17 and 3) A bilateral Tinel sign at the tarsal tunnel (n. tibialis posterior) Sufficient circulation to heal lower-extremity incision (by palpating the peripheral arteries of the foot: a palpable dorsal pedis artery or posterior tibial artery is needed). In case of non-palpable arteries a pedal Doppler arterial waveform is evaluated. A toe brachial index is performed when the Doppler signal is not triphasic· Minimal or controlled pedal oedema (assessed with inspection and physical examination) Being fit for surgery Compliant with instructions for their own care* Intact protective sensation (cutaneous threshold

Exclusion criteria

Exclusion criteria: DFU(s) or amputation(s) in history, active radicular syndrome or neurological disease interfering with sensation of the feet, as assessed in the interview and screening questionnaire (e.g. HIV and chemotherapy induced neuropathy) Previous surgery at lower extremity nerve compression sites Active Charcot foot Not able to understand written and oral instructions (i.e. insufficient command of Dutch language) Being incompetent (incapacitated) Current enrollment in a clinical trial which involves surgery of the lower extremity or medical drug trials investigating the effects on neuropathy symptoms. HbA1c level > 11% at baseline Pregnant women

Design outcomes

Primary

MeasureTime frame
Complaints (Norfolk QoL-DN).

Secondary

MeasureTime frame
Quality of life (EQ-5D5L, SF-36), plantar sensation, incidence of ulcerations/amputations and resource use during follow-up. The incremental cost-utility ratio will be estimated on the basis of the collected empirical data.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)